Using amyloid PET imaging to diagnose Alzheimer's disease in patients with multiple sclerosis.

Magdalena KolankoZarni WinNeva PatelOmar MalikChristopher CarswellAnastassia GontsarovaRichard NicholasRichard PerryParesh A Malhotra

Published in: Journal of neurology (2020)

The experience from this case series suggests that Amyloid PET Imaging may be of diagnostic value in selected patients with MS and dementia. In these individuals, it may provide diagnostic clarity and assist with therapeutic decisions.

Keyphrases

pet imaging
positron emission tomography
mild cognitive impairment
mass spectrometry
multiple sclerosis
cognitive decline
ms ms
pet ct